Chenqi Xu

Wenzhou Medical University — China

Immunology and Microbiology · Life Sciences

36h-index7.9kcitations122works4.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(47), T-cell and B-cell Immunology(27), CAR-T cell therapy research(27), Monoclonal and Polyclonal Antibodies Research(13), Ion channel regulation and function(12)

Publications122 total

Droplet-Based Facile Deciphering of Heterogeneous Glycans in Extracellular Vesicles down to the Single-Particle Level
Analytical Chemistry·2026
CRAMA: Cross-Attention Mamba for Trajectory Prediction in Autonomous Driving
Lecture notes in computer science·2026
Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies
Advanced Science·2025· 1 citedOpen Access
Interpretable Interaction Modeling for Trajectory Prediction via Agent Selection and Physical Coefficient
2025· 1 cited
Lipid-regulated phosphorylation hierarchy of the T cell receptor tyrosine motifs
Molecular Cell·2025· 1 cited
Amplifying antigen-induced cellular responses with proximity labelling
Nature·2025· 11 cited
Touch of youth: Mechanosensing expands stem-like CAR-T cells
Immunity·2025· 1 cited
Technologies for chimeric antigen receptor transgene delivery
Trends in Molecular Medicine·2025· 1 cited
Magnesium Lithospermate B Protects Against Ischemic AKI-to-CKD progression via regulating the KLF5/CDK1/Cyclin B1 pathway
Phytomedicine·2025· 2 cited
Ligand-induced ubiquitination unleashes LAG3 immune checkpoint function by hindering membrane sequestration of signaling motifs
Cell·2025· 45 citedOpen Access
Phase separation of chimeric antigen receptor promotes immunological synapse maturation and persistent cytotoxicity
Immunity·2024· 23 cited
Charge-based immunoreceptor signalling in health and disease
Nature reviews. Immunology·2024· 7 cited
Publisher Correction: Cytoplasmic FBXO38 mediates PD-1 degradation
EMBO Reports·2024Open Access
Supplementary Figure S2 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
2024Open Access
Supplementary Figure S8 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
2024Open Access
Supplementary Table 1 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
2024Open Access
Data from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
2024Open Access
Supplementary Figure S6 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
2024Open Access
Supplementary Figure S3 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
2024Open Access
Supplementary Figure S7 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
2024Open Access
page 1 of 7Next →

Frequent Co-authors

Haopeng Wang(10), Wanli Liu(9), Xingdong Guo(8), Xiaoshan Shi(8), Wei Wu(7), Wei Yang(6), Lunyi Li(6), Yibing Bai(5), Kai W. Wucherpfennig(5), Hua Li(5), Xinyi Xu(5), Cheng‐Wu Chi(5), Chengsong Yan(4), Bao‐Liang Song(4), Matthew E. Call(4), Shutan Jiang(4), Manman Xue(4), Haochen Yang(4), Jan Tytgat(4), Xing He(3)